Literature DB >> 1855350

Gentamicin population pharmacokinetic models for low birth weight infants using a new nonparametric method.

W F Dodge1, R W Jelliffe, C J Richardson, R A McCleery, J A Hokanson, W R Snodgrass.   

Abstract

Availability of personal computer programs for control of drug regimens has stimulated interest in modeling population pharmacokinetics. In this study, we found parameter values for gentamicin in two infant populations with low birth weights. The models were developed by use of a parametric (i.e., standard two-stage algorithm) and with a new nonparametric expected maximum algorithm. Data for the two populations (i.e., infants less than or equal to 31 weeks' and greater than 31 but less than or equal to 34 weeks' gestational age) were obtained from infants admitted to the University of Texas Medical Branch intensive care nursery between August 1, 1988, and July 31, 1989. The new nonparametric method was demonstrated to be not only the equal of the standard two-stage method for population modeling but better, especially in use of sparse data sets (e.g., single serum levels). It also obviates the need for selecting proper starting conditions for the least-squares fitting procedure used in the standard two-stage method.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1855350     DOI: 10.1038/clpt.1991.100

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  17 in total

1.  Application of a gamma model of absorption to oral cyclosporin.

Authors:  J Debord; E Risco; M Harel; Y Le Meur; M Büchler; G Lachâtre; C Le Guellec; P Marquet
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  Pharmacokinetic modelling of intravenous tobramycin in adolescent and adult patients with cystic fibrosis using the nonparametric expectation maximization (NPEM) algorithm.

Authors:  D J Touw; A A Vinks; C Neef
Journal:  Pharm World Sci       Date:  1997-06

3.  Bayesian pharmacokinetic analysis of a gentamicin nomogram in neonates: a retrospective study.

Authors:  Robert E Ariano; Daniel S Sitar; Maria Davi; Sheryl A Zelenitsky
Journal:  Curr Ther Res Clin Exp       Date:  2003-03

4.  Gentamicin pharmacokinetics in preterm infants with a patent and a closed ductus arteriosus.

Authors:  D J Touw; J H Proost; R Stevens; H N Lafeber; M M van Weissenbruch
Journal:  Pharm World Sci       Date:  2001-10

5.  Assessment of bioelectrical impedance for individualizing gentamicin therapy in neonates.

Authors:  J S Sidhu; B G Charles; E J Triggs; D I Tudehope; P H Gray; P A Steer
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  Nonparametric approach to population pharmacokinetics in oncology patients receiving aminoglycoside therapy.

Authors:  J F Inciardi; K K Batra
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

7.  Population pharmacokinetics of gentamicin. Use of the nonparametric expectation maximisation (NPEM) algorithm.

Authors:  D F Kisor; S M Watling; B J Zarowitz; R W Jelliffe
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

Review 8.  Therapeutic drug monitoring of aminoglycosides in neonates.

Authors:  Daniël J Touw; Elsbeth M Westerman; Arwen J Sprij
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

9.  Comparison of population pharmacokinetic models for gentamicin in spinal cord-injured and able-bodied patients.

Authors:  T M Gilman; S R Brunnemann; J L Segal
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

Review 10.  Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.

Authors:  Jessica K Roberts; Chris Stockmann; Jonathan E Constance; Justin Stiers; Michael G Spigarelli; Robert M Ward; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2014-07       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.